GlaxoSmithKline (GSK) to Close U.K. Research Center - DJN
According to a Dow Jones Newswire, GlaxoSmithKline (NYSE: GSK) is to shutter a U.K. research center following the completion of a study on pain relief, anxiety, and depression.
The loss of jobs would amount to about 380.
Create E-mail AlertRelated Categories
General NewsStocks Mentioned
-0.31Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
